@net_connectinfo NET CONNECT

NET CONNECT posts on X about education, study, future, update the most. They currently have [-----] followers and [---] posts still getting attention that total [-------] engagements in the last [--] hours.

Engagements: [-------] #

Mentions: [--] #

Followers: [-----] #

CreatorRank: [-------] #

Social Influence

Social category influence nba technology brands countries social networks travel destinations finance stocks

Social topic influence education #1332, study, future, update, virtual, youtube, barcelona, australia, strong, how to

Top accounts mentioned or mentioned by @ncukcharity @curenets @amanchauhanmd @jacapdevila @ncfcancer @netconnectinfo @nanets1 @helops79 @oncbrothers @profkherrmann @gicancer @louisdemestier @netcancerday @necanceraus @drangelalamarca @civesmauro @drenriquegrande @profmc @rachelriechelm2 @cronajoakim

Top assets mentioned Spotify Technology (SPOT)

Top Social Posts

Top posts by engagements in the last [--] hours

"💬Surgeons have debated whether to perform prophylactic surgery for asymptomatic pts w/ metastatic #SBNETs to improve OS. Retrospective accounts suggest yes but recent studies & professional attention challenge this idea. ❓What's the answer #MedEd"
X Link 2023-08-11T08:00Z [---] followers, [--] engagements

"📚 New to our #MedEd series Begin your journey with the accredited Module [--] of our microlearning series Dive into the world of #SSAs in #NETs progression with expert insights from Dr @AmanChauhanMD and Prof Martin Caplin"
X Link 2023-09-12T09:00Z [---] followers, [---] engagements

"📚 Ready to deepen your #MedEd journey into #NETs Dive into Module [--] led by oncologists @Ja_Capdevila & @cives_mauro. Become a #NET expert master symptom spotting precise diagnosis & excel referrals to #NET centers"
X Link 2023-09-13T09:00Z [---] followers, [--] engagements

"Our micro learning on how to recognise diagnose and manage NETs is freely available. Download the flashcard and slides and watch the short video #NETs"
X Link 2023-09-28T10:21Z [---] followers, [---] engagements

"Given their rarity breast #NETs may be challenging to diagnose and treat🤔 Raising awareness among healthcare providers about the existence of these tumors is essential for timely diagnosis and appropriate management 🩺💡 #BreastCancerAwarenessMonth"
X Link 2023-10-09T09:35Z [---] followers, [---] engagements

"#ESMO23 is almost here Get ready for inspiring talks and discussions on #NETs with some key sessions you won't want to miss listed below👇 Don't forget to come and say 👋 at BOOTH 576👀🗣 #Neuroendocrinetumours #MedEd"
X Link 2023-10-19T09:01Z [---] followers, [---] engagements

"💭Loads of discussions on #NETs over the last few days at #ESMO23. 👇🏼Here are some of the main take-home messages from expert @DrAngelaLamarca👇🏼 What information was most interesting or relevant to your clinical practice #MedEd"
X Link 2023-10-24T10:08Z [---] followers, [---] engagements

"From basic research to practice shaping clinical trials: #ESMO23 did not disappoint us when it comes to #NETs. 📊📉Check out some of the posters as highlighted by @DrAngelaLamarca. 👏🏼Congratulations to the authors #MedEd"
X Link 2023-10-24T10:16Z [---] followers, [---] engagements

"🔎Exploring the potential of 68GaGa-FAPI-04 PET/CT as an alternative diagnostic/theranostic tool in well-differentiated #NETs refractory to 177LuLu-DOTATATE therapy. Preliminary findings suggest limited role urging further investigation. #MedEd"
X Link 2023-11-13T23:29Z [---] followers, [---] engagements

"📚📊Learn more about #NETs and how to recognise & diagnose presenting symptoms. Join us in this 2-part microlearning programme with medical oncologists & earn #CME credit - get your knowledge refreshed & understanding deepened #MedEd"
X Link 2023-11-20T09:00Z [---] followers, [---] engagements

"Gastric #NETs can exhibit various behaviours from indolent to more aggressive forms. Early diagnosis & a comprehensive understanding of the specific characteristics are crucial for improved patient outcomes. #LetsTalkAboutNETs #MedED 👇👇👇"
X Link 2023-11-20T23:15Z [---] followers, [---] engagements

"💭🔬Exploring G-NETs: rare diverse and challenging. Learn about their unique features associated syndromes and diverse treatment approaches in this insightful review. #MedEd #NEts"
X Link 2023-12-16T09:15Z [---] followers, [---] engagements

"Explore our #NETs micro-learning programme 🧠💡 🚑Recognize symptoms explore diagnosis steps and understand the importance of referral to a #NET center. Access video resources and assessment now #MedEd 🎓Complete both modules for a CME credit"
X Link 2023-12-21T08:01Z [---] followers, [--] engagements

"Shocking numbers It's time to spread awareness know the symptoms and advocate for early detection of lung #NETs. 👇👇👇 In #SCAN 68% of lung NET patients describe time to diagnosis taking more than one year with more than a third waiting more than [--] years. HCPs can suspect NET being aware of the disease. ☑Share #NETInfo in your language: https://t.co/ekWhXLmXPv #LetsTalkAboutNETs #LungTwitter https://t.co/77QTils84l In #SCAN 68% of lung NET patients describe time to diagnosis taking more than one year with more than a third waiting more than [--] years. HCPs can suspect NET being aware of the"
X Link 2024-01-24T10:01Z [---] followers, [---] engagements

"Explore our #NETs micro-learning programme 🧠💡 🚑Recognize symptoms explore diagnosis understand the importance of referral to a #NET center. Access videos and resources to enhance your skill-set #MedEd 🎓Complete both modules for a CME credit"
X Link 2024-01-27T10:00Z [----] followers, [---] engagements

"📢The European Neuroendocrine Tumour Society will hold its 21st Annual Conference 13-15 March [----] Explore the latest in #NETs diagnostics and therapeutics over two days with additional sessions for nurses and dieticians. #ENET #MedEd"
X Link 2024-02-15T10:15Z [----] followers, [---] engagements

"Our global survey on acromegaly and #NETs treatment experiences was published in August #MedEd 📚 Read the paper to learn about crucial insights from patients caregivers and healthcare professionals. Download the survey overview below"
X Link 2024-02-25T10:00Z [----] followers, [---] engagements

"🔍New analysis of early-onset colorectal cancer trends in US adults (25-54 years). #NETs show significantly greater increase compared to ADC especially in males & early-stage tumors. Early screening crucial for improved outcomes. #MedEd"
X Link 2024-02-26T05:35Z [----] followers, [---] engagements

"Explore our #NETs micro-learning programme 🧠💡 🚑Recognize symptoms explore diagnosis understand importance of referral to a #NET center. Access video slides flashcard to enhance your skill-set #MedEd 🎓Complete both modules for a CME credit"
X Link 2024-02-29T11:00Z [----] followers, [---] engagements

"📢As March begins let's remember the distinctive challenges presented by #NETs as rare diseases. And every #RareDiseaseDay dedicate some time to learn more about #NETs with our free-to-access #MedEd programmes. Stay tuned for more to come 🔜"
X Link 2024-03-04T08:10Z [----] followers, [---] engagements

"🔬 New findings show that PITX2 expression may serve as a sensitive (98.1%) and specific (99.5%) marker for midgut-derived #NETs suggesting potential integration into diagnostic panels to enhance accuracy in #NET classification. #MedEd https://ow.ly/2NMM50QPUrS https://ow.ly/2NMM50QPUrS"
X Link 2024-03-13T09:01Z [----] followers, [---] engagements

"⚠Did you know Stomach distress can be a symptom of #NETs. Early detection and management are crucial for better outcomes. Stomach distress might also indicate #pheo #para -- know the signs of this #NETs disease. 🤢🤮 https://t.co/jDm3w5prNg Stomach distress might also indicate #pheo #para -- know the signs of this #NETs disease. 🤢🤮 https://t.co/jDm3w5prNg"
X Link 2024-03-20T09:00Z [----] followers, [---] engagements

"❓Do you know how to recognize symptoms of #NETs Improve your skills in our micro learning programme Explore #pancreatic #gastric #rectal & appendiceal #NETs and understand the importance of NET centre referral. Access the video & resources below https://ow.ly/G8Gx50QVjko https://ow.ly/G8Gx50QVjko"
X Link 2024-03-23T09:00Z [----] followers, [---] engagements

"Phase [--] clinical trial update in #NETs 📊 Combination therapy with lenvatinib and pembrolizumab in advanced GI/thoracic NETs. Out of [--] patients 10% achieved a partial response lower than in monotherapy with a median PFS of [--] months. #MedEd https://ow.ly/OCVe50R0V1z https://ow.ly/OCVe50R0V1z"
X Link 2024-03-29T09:00Z [----] followers, [---] engagements

"⚡📢Breaking News: #Lutetium Lu [---] dotatate (Lutathera) has been approved by @US_FDA for pediatric patients (12 years+) with #SSTR-positive GEP-NETs. This marks the first FDA approval of a radioactive drug for this age group. More info here: #MedEd https://ow.ly/OA2K50RqfTw https://ow.ly/OA2K50RqfTw"
X Link 2024-04-29T06:27Z [----] followers, [---] engagements

"#MedEd opportunity Dive into our two-part micro-learning series to learn about Recognising Diagnosing and Managing #NETs as well as strategies for continuing SSA in patients with Grade 1/2 & slowly progressive asymptomatic disease. Check out now https://ow.ly/Ti8k50Ru8By+ https://ow.ly/Ti8k50Ru8By+"
X Link 2024-05-05T08:00Z [----] followers, [---] engagements

"🚨Event alert Join @LACNETS educational event on high grade #NETs and small cell lung cancer with Dr Aman Chauhan on the 7th of May at 16:30 UK time Check out the details below https://x.com/LACNETS/status/1786434460738535540 Join us on Tuesday May 7th at 8:30 AM Pacific to learn about the latest in high grade neuroendocrine neoplasms and small cell lung cancer with medical oncologist Dr. Aman Chauhan. ➡➡Register at https://t.co/pU02R7IeP2 https://t.co/vS9ZBd6f1r https://x.com/LACNETS/status/1786434460738535540 Join us on Tuesday May 7th at 8:30 AM Pacific to learn about the latest in high"
X Link 2024-05-06T13:39Z [----] followers, [---] engagements

"🎙New #NETs Podcast Alert Dive into the regional differences in #NET epidemiology diagnosis and referral strategies with oncology experts Prof. Martyn Caplin and Prof. Rachel Riechelmann. Head to our website for episode 1: @Prof_M_C @RachelRiechelm2 https://ow.ly/2ekz50S1Kaf https://ow.ly/2ekz50S1Kaf"
X Link 2024-05-30T09:57Z [----] followers, [---] engagements

"🚨🎧Catch up with our brand new podcast series on #NETs In episode [--] Prof. Martyn Caplin & Prof. Rachel Riechelmann delve into optimising treatment for NET patients and explore future advances in the field. 👉 #MedEd @Prof_M_C @RachelRiechelm2 https://ow.ly/QeGk50S6sog https://ow.ly/QeGk50S6sog"
X Link 2024-06-03T06:56Z [----] followers, [---] engagements

"#NETs which can present with nonspecific symptoms like abdominal pain diarrhea & weight loss are often misdiagnosed as more common GI disorders like IBS or chronic gastritis. Accurate diagnosis is crucial for effective treatment & management #MedEd https://x.com/netcancerday/status/1799758337489178777 Often NET patients go back to #primarycare with GI symptoms and are referred to a #gastroenterologist. 👉If HCPs know about NETs they will have a low threshold to push for a CT scan. ✅Download #NETInfo in [--] languages: https://t.co/ekWhXLmpZX #LetsTalkAboutNETs https://t.co/ta3kZm6ZXn"
X Link 2024-06-10T06:19Z [----] followers, [---] engagements

"Catch up on the second episode of the latest podcast on #neuroendocrinetumours with Prof. Martyn Caplin and Prof. Rachel Riechelmann discussing treatment optimisation and future developments in the field Episode 2: Spotify Apple YouTube #MedEd #LetsTalkAboutNETs https://youtu.be/zd_JvUmIhFgsi=DfM0npSbbuhoq5hw https://podcasts.apple.com/podcast/cor2ed-medical-education/idid1719836050i=1000657039004 https://open.spotify.com/episode/5q5xNDgR2BVcE1LvRT6n9L https://cor2ed.com/net-connect/programmes/regional-differences-neuroendocrine-tumours-nets-2/"
X Link 2024-06-10T12:32Z [----] followers, 159.4K engagements

"🚨Dive deep into the world of #NETs in our new podcast series 🎧Ep 1: Treatment strategies & regional differences: 🎧Ep 2: Real-world treatment regional practices and future developments: Stay informed tune in now #MedEd https://ow.ly/EGQ050Scvcv https://ow.ly/QpQi50ScvcE https://ow.ly/EGQ050Scvcv https://ow.ly/QpQi50ScvcE"
X Link 2024-06-14T08:00Z [----] followers, [---] engagements

"📜#NETs are increasingly diagnosed due to improved detection. CT MRI & PET/CT are crucial for detection & planning but each has its own challenges. Check out this recent review that covers advances in NEN imaging diagnosis & management. #MedEd https://ow.ly/Xyw150So1Ol https://ow.ly/Xyw150So1Ol"
X Link 2024-06-26T08:00Z [----] followers, [---] engagements

"🔥 Exciting news Our upcoming micro learning is on the way Don't miss out stay tuned to join Prof. Emily Bergsland & Asst. Prof. Louis de Mestier as they explore tools for optimising treatment & management of advanced #NETs. #NETs #MedEd @louis_demestier"
X Link 2024-07-18T10:28Z [----] followers, [---] engagements

"🗣Catch up on the latest advancements and expert discussions in #neuroendocrine tumours with the on-demand video of the latest @ENETS_ORG @NANETS1 joint educaional webinar. #MedEd #NETs #LetsTalkAboutNETs https://x.com/ENETS_ORG/status/1815655588929716479 A huge thank you to everyone who made the @ENETS_ORG and @NANETS1 educational collaboration a success Missed the two kickoff webinars No worries 🎉 You can watch them for free in the ENETS webinar archive. Check them out here: https://t.co/Elr1ADoszN https://x.com/ENETS_ORG/status/1815655588929716479 A huge thank you to everyone who made the"
X Link 2024-07-23T10:43Z [----] followers, [---] engagements

"📊Recent study on PCSK2 in #GI-NETs found 50% duodenal 59% pancreatic 40% ileal but 0% stomach and 25% rectal cancer types. A panel with PCSK2 ISL1 NKX2.2 CDX2 SATB2 achieved 87% sensitivity and 93% specificity for ileal #NETs. #MedEd https://ow.ly/LoVK50SHYPB https://ow.ly/LoVK50SHYPB"
X Link 2024-07-24T08:01Z [----] followers, [---] engagements

"Did you know SCNC & LCNC are often linked to HPV (mostly HPV18/16) 🦠 Cervical #NETs may be genetically closer to common cervical cancers than to lung/bladder SCNEC. Early-stage treatment usually involves surgery & chemo but recurrence is challenging. https://ow.ly/Tra850SRV34 https://ow.ly/Tra850SRV34"
X Link 2024-08-06T10:44Z [----] followers, [---] engagements

"Are you ready to optimize your approach to advanced #NETs 🎓 Discover how to optimise treatment strategies while balancing tumour specifics & patient QoL on our new micro-learning with Prof Emily Bergsland & Asst Prof. Louis de Mestier. #MedEd https://ow.ly/qRJu50SVjhq https://ow.ly/qRJu50SVjhq"
X Link 2024-08-11T09:35Z [----] followers, [---] engagements

"🤩The excitement is building @myESMO The #ESMO Congress [----] is coming up in Barcelona and online where we expect to see new data on #NETs and other groundbreaking cancer research. 👀Will you be there You can still register here: https://ow.ly/iasb50T5Xci https://ow.ly/iasb50T5Xci"
X Link 2024-08-27T20:00Z [----] followers, [---] engagements

"🎙 Check out our new podcast series on #NETs Join Profs. Martyn Caplin & Rachel Riechelmann as they dive into NET epidemiology diagnosis & referral strategies. Listen to Ep [--] now: Spotify 👉 YouTube 👉 https://ow.ly/3L7H50T5YNx https://ow.ly/iuTt50T5YNv https://ow.ly/nKal50T5YNw https://ow.ly/3L7H50T5YNx https://ow.ly/iuTt50T5YNv https://ow.ly/nKal50T5YNw"
X Link 2024-08-28T20:01Z [----] followers, [---] engagements

"📚 Earn CME credits and download resources with our new micro learning on advanced #NETs Prof. Emily Bergsland & Prof. Louis de Mestier cover key topics including optimal management and tools for assessing therapeutic success. #MedEd https://cor2ed.com/net-connect/programmes/treatment-management-advanced-nets/ https://cor2ed.com/net-connect/programmes/treatment-management-advanced-nets/"
X Link 2024-09-06T12:42Z [----] followers, 92.6K engagements

"#ESMO2024 I AB1146MO 📊Promising results from the CABONEN phase II trial: Cabozantinib shows efficacy in low-proliferative #NEN G3 patients (Ki67 20-60%). Primary endpoint DCR at [--] months was 64.1% with PFS [---] months. No new safety concerns reported. #MedEd"
X Link 2024-09-15T04:31Z [----] followers, [---] engagements

"🔥 #ESMO2024 I ABS1141O CABINET Trial/Alliance A021602 update: Cabozantinib (CABO) outperforms placebo in advanced #NETs Median PFS was [----] months for CABO vs. [---] months for placebo (HR=0.55 p0.001). ORR was 22.7% with CABO vs. 10.3% with placebo (p=0.03). #MedEd"
X Link 2024-09-17T03:30Z [----] followers, [---] engagements

"📢🔥Dive into the latest @SpringerNature edition on #NETs covering pathology molecular biology diagnostics and treatment options. Authored by leading experts it's a valuable resource for oncologists endocrinologists and HCPs. #MedEd https://ow.ly/T96o50TFyqr https://ow.ly/T96o50TFyqr"
X Link 2024-10-07T12:00Z [----] followers, [---] engagements

"❓Did you know that #NETs can be associated with genetic syndromes 🧬Conditions such as MEN types [--] & [--] von Hippel-Lindau disease and neurofibromatosis type [--] increase the risk of NETs. 👇Check out the latest factsheets from @netcancerday #MedEd https://x.com/netcancerday/status/1842520112072737276 NETs can be linked to genetic syndromes. ✅Help the doctors you know to learn about genetic NETs in [--] languages: https://t.co/ekWhXLmXPv #LetsTalkAboutNETs #MultipleEndocrineNeoplasia #Pheochromocytoma #Paraganglioma #OncTwitter #EndoTwitter #MedTwitter #MedEd https://t.co/DQXvnJJWdk"
X Link 2024-10-08T08:01Z [----] followers, [---] engagements

"🎙If you missed it now's the time to tune in Watch @DrMohidKhan & patient advocate Sally Jenkins discuss the importance of shared decision-making in #NETs including patient preference for at-home treatment. #MedEd https://ow.ly/4xE550TFyUa https://ow.ly/4xE550TFyUa"
X Link 2024-10-09T08:01Z [----] followers, [---] engagements

"🎥Join experts Prof. Bergsland & Prof. @louis_demestier in our CME-accredited microlearning on #NETs Aspects covered include tumour- patient- and treatment-related factors. #MedEd https://ow.ly/6Iyl50TNi0Q https://ow.ly/6Iyl50TNi0Q"
X Link 2024-10-17T06:18Z [----] followers, [---] engagements

"Update on #GEP-NEN biomarkers 📝 [---] studies [--] key recommendations and expert insights on imaging biomarkers and treatment of midgut NETs with carcinoid syndrome. Dive right into it in @JAMAOnc: #MedEd https://ow.ly/4HnM50TNa5z https://ow.ly/4HnM50TNa5z"
X Link 2024-10-20T08:00Z [----] followers, [---] engagements

"NETs: Understanding key clinical studies like COMPETE and NETTER-1 and [---] helps you pair the right patient with the right treatment ✅ What else do you need to know about radiopharmaceutical treatment for #NETs Experts discuss management strategies future directions and more 📹 Video from Dr @helops79 @ProfKHerrmann @OncBrothers 🤝 Endorsed by @NANETS1 CommNETs (@GICancer) & @ncukcharity Supported by an Independent Educational Grant from ITM #MedEd #OncTwitter #MedTwitter #EndoTwitter"
X Link 2025-10-17T12:24Z [----] followers, [----] engagements

"Expert perspectives on PRRT and emerging strategies in #neuroendocrine tumours Explore diagnostic strategies pt selection based on clinical trials safety profiles/AE mgmt future directions & more Here's a short video teaser. see the full video & find out more Supported by an Independent Educational Grant from ITM #MedEd https://cor2ed.com/net-connect/programmes/targeted-radiopharmaceutical-treatment-nets/media=0 https://cor2ed.com/net-connect/programmes/targeted-radiopharmaceutical-treatment-nets/media=0"
X Link 2025-10-21T09:50Z [----] followers, [---] engagements

"Exploring the role of targeted radiopharmaceutical treatment in #NETs Experts discuss PRRT and emerging strategies in #neuroendocrine tumours w/ Dr @helops79 @ProfKHerrmann Moderated by @OncBrothers 📹 Watch the video 🤝 Endorsed by @NANETS1 CommNETs (@GICancer) & @ncukcharity Supported by an Independent Educational Grant from ITM #MedEd #OncTwitter #MedTwitter #EndoTwitter"
X Link 2025-11-28T13:27Z [----] followers, [--] engagements

"Navigating extrapulmonary neuroendocrine carcinoma (EP-NEC) Insights for patients and care partners 📺 Video in this post Get the key takeaways: 🤝Endorsed by: INCA (@netcancerday) @NECancerAus @ncukcharity @NCFCancer @CureNETs & Minkahz NETs Mission Supported by an Independent Educational Grant from Boehringer Ingelheim #MedEd #PatientEducation https://cor2ed.com/net-connect/programmes/extrapulmonary-neuroendocrine-carcinoma-ep-nec/media=0 https://cor2ed.com/net-connect/programmes/extrapulmonary-neuroendocrine-carcinoma-ep-nec/media=0"
X Link 2025-12-12T12:29Z [----] followers, [--] engagements

"Check out our recent #NETs video 📹 Expert perspectives on PRRT and emerging strategies in #neuroendocrine tumours - Explore diagnostic strategies pt selection based on clinical trials safety profiles/AE mgmt future directions & more w/ Dr @helops79 @ProfKHerrmann @OncBrothers 🤝 Endorsed by @NANETS1 CommNETs (@GICancer) & @ncukcharity Supported by an Independent Educational Grant from ITM #MedEd #OncTwitter #MedTwitter #EndoTwitter"
X Link 2025-12-12T14:12Z [----] followers, [---] engagements

"Understanding EP-NEC: Through diagnosis treatment and support What do you need to know Video podcast from Medical Oncologist Dr @AmanChauhanMD + Neuroendocrine Patient Advocate Susan Meckler-Plummer RN Get answers to questions such as: -How are NETs and NECs different from one another -Why is there such urgency when treating EP-NECs -What needs remain for treatment -What support is available for patients and care partners 📹 Watch the highlights in this post Watch the full video or listen on Spotify/Apple: Endorsed by Minkahz NETs Mission @ncukcharity @NCFCancer and @CureNETs For more"
X Link 2026-01-05T12:32Z [----] followers, [---] engagements

"Dr @helops79 @ProfKHerrmann & @OncBrothers share their perspectives on advances in the management of #neuroendocrine tumours Spotlight on the role of radioligand therapy and its impact on clinical practice 🔦 📹 Video in this post 🤝 Endorsed by @NANETS1 CommNETs (@GICancer) & @ncukcharity Supported by an Independent Educational Grant from ITM #MedEd #OncTwitter #MedTwitter #EndoTwitter #NETs"
X Link 2026-01-23T14:16Z [----] followers, [---] engagements

"Unlike most NETs EP-NECs are poorly differentiated high-grade aggressive and fast-growing cancers with a need for more effective treatments But how do you distinguish between NECs and NETs And what does this mean for patients Get the answers in this video podcast 📹 Highlights in this post Watch the full video or listen on Spotify/Apple: 🤝 Endorsed by Minkahz NETs Mission @ncukcharity @NCFCancer and @CureNETs For more information or support please speak with an HCP or reach out to a local patient advocacy group in your country or region Supported by an Independent Educational Grant from"
X Link 2026-02-02T12:40Z [----] followers, [---] engagements

"Understanding EP-NEC: Through diagnosis treatment and support What do you need to know Video podcast from Medical Oncologist Dr @AmanChauhanMD + Neuroendocrine Patient Advocate Susan Meckler-Plummer RN Get answers to questions such as: -How are NETs and NECs different from one another -Why is there such urgency when treating EP-NECs -What needs remain for treatment -What support is available for patients and care partners 📹 Watch the highlights in this post Endorsed by Minkahz NETs Mission @ncukcharity @NCFCancer and @CureNETs For more information or support please speak with an HCP or"
X Link 2026-02-03T13:14Z [----] followers, 297.6K engagements

"Navigating extrapulmonary neuroendocrine carcinoma (EP-NEC) This is a rare and complex cancer that needs early diagnosis and intervention 📺 Watch the video from Meredith Cummins INCA President-Elect and CEO of NeuroEndocrine Cancer Australia to find out - Why urgency is needed in diagnosis & treatment - The potential of investigational treatments - Where to find support 🤝Endorsed by: INCA (@netcancerday) @NECancerAus @ncukcharity @NCFCancer @CureNETs & Minkahz NETs Mission See more & get the key takeaways: Supported by an Independent Educational Grant from Boehringer Ingelheim #MedEd"
X Link 2026-02-13T16:33Z [----] followers, [--] engagements

"Brand new podcast series on #neuroendocrinetumours. Listen to Prof. Martyn Caplin & Prof. Rachel Riechelmann discuss NET epidemiology diagnosis and referral strategies Episode [--] Apple YouTube #MedEd #LetsTalkAboutNETs https://youtu.be/6fKAxS4u-2osi=uEkqMSEfDjXa5s8m https://podcasts.apple.com/podcast/cor2ed-medical-education/idid1719836050i=1000657036427 https://open.spotify.com/episode/3CB3fTp7vxQOHG9XvMSwYO https://cor2ed.com/net-connect/programmes/regional-differences-neuroendocrine-tumours-nets-1/ https://youtu.be/6fKAxS4u-2osi=uEkqMSEfDjXa5s8m"
X Link 2024-06-10T12:26Z [----] followers, 393.2K engagements

"Now available Explore the evolving role of PRRT in NETs Tap to enlarge the infographic📜 Optimising treatment strategies needs an understanding of the clinical trial data and how studies differ View the infographic to differentiate between key clinical studies including COMPETE & NETTER-1 and [---] to help you pair the right patient with the right treatment From Dr @helops79 @ProfKHerrmann @OncBrothers Endorsers: @NANETS1 CommNETs (@GICancer) & @ncukcharity Supported by an Independent Educational Grant from ITM"
X Link 2025-10-06T08:00Z [----] followers, 148.1K engagements

"There remains an unmet treatment need for extra-pulmonary neuroendocrine carcinomas but emerging clinical data with DLL3-targeted agents are promising. Alongside treatment advances access to strong support networks remains vital for patients and their care partners. Listen along in this Podcast with Medical Oncologist Dr Aman Chauhan and Patient Advocate Susan Meckler-Plummer to learn more: Spotify: Apple Podcasts: This educational programme is supported by an Independent Educational Grant from Boehringer Ingelheim"
X Link 2026-01-12T14:24Z [----] followers, [---] engagements

"Great to be in Barcelona at our first ENETS conference #ENETS19"
X Link 2019-03-07T11:27Z [----] followers, [--] engagements

"Great sessions this morning @ #ENETS19 on nuclear medicine PRRT and impact on response assessment"
X Link 2019-03-08T14:05Z [----] followers, [--] engagements

"@net_connectinfo On NET cancer day proud to raise awareness of NET through our independent medical education programs. #NETCancerDay"
X Link 2019-11-10T21:21Z [----] followers, [--] engagements

"Recognising World Cancer Day today and all patients affected by cancer. Continuing to raise awareness and contribute to medical education for neuroendocrine tumours and new treatments. #WCD2020 #oncology #MedEd #NETS"
X Link 2020-02-04T07:36Z [----] followers, [--] engagements

"Nice NET presentations given during the Improving outcomes for GI cancers symposium today at #WorldGI2020 presented by two #NETCONNECT members @Ja_Capdevila and @louis_demestier. #MedEd #oncology"
X Link 2020-07-02T22:11Z [----] followers, [--] engagements

"Lanreotide [---] mg every [--] weeks shows promising PFS in midgut #NETs and panNETs. Great presentation by ENETS Chair and NET Connect member Prof. Marianne Pavel. #ENETS [----] #ENETS [----] #MedEd #Oncology"
X Link 2021-02-25T14:51Z [----] followers, [--] engagements

"NET CONNECT member Dr.Angela Lamarca gave an excellent presentation at #ENETS21 today regarding considerations for #NEN patients who have not yet had children or are pregnant. #ENETS2021 #Oncology #MedEd"
X Link 2021-02-27T12:01Z [----] followers, [--] engagements

"#ASCO21: Results from Halperin et al. from the phase [--] trial with PEN-221 SSA-DM1 conjugate in patients with advanced GI mid-gut NETs showed a clinical benefit rate of 88.5% and a median PFS of [--] months. #NET #MedEd #oncology http://ow.ly/6aUG50F5V13 http://ow.ly/6aUG50F5V13"
X Link 2021-06-08T21:38Z [----] followers, [--] engagements

"Wednesday [--] November is World NET Cancer Day a day to increase awareness of #neuroendocrine cancers. On this day ENETS and INCA organise an educational webinar for patients and patient advocates. @netcancerday #LetsTalkAboutNETs #NETCancerDay https://www.enets.org/net-cancer-awareness-day.html https://www.enets.org/net-cancer-awareness-day.html"
X Link 2021-11-09T17:01Z [----] followers, [--] engagements

"The next #ENETS webinar will discuss the "post-OMICS" landscape and agnostic strategy in #NET and will be moderated by @drenriquegrande NET CONNECT member @CronaJoakim and @JustoCastano. Wednesday [--] November 18:00-19:40 CEST #MedEd #Oncology http://ow.ly/k1EI50GSOeZ http://ow.ly/k1EI50GSOeZ"
X Link 2021-11-22T14:00Z [----] followers, [--] engagements

"Here is an excellent guide that can help you as a clinician to best approach metastatic #NENs of unknown primary utilising histological assessments and auxiliary analyses of value. NEN-UPs from a pathologists perspective. 👉🏼 #MedEd #LetsTalkAboutNETs http://ow.ly/ORCO50J8Kwz http://ow.ly/ORCO50J8Kwz"
X Link 2022-05-21T19:00Z [----] followers, [--] engagements

"Exciting news Our microlearning on how to recognize diagnose and manage NETs developed by @Ja_Capdevila and @cives_mauro is live Access the video flashcard and slide deck from the link below: https://cor2ed.com/net-connect/programmes/managing-neuroendocrine-tumours/ https://cor2ed.com/net-connect/programmes/managing-neuroendocrine-tumours/"
X Link 2023-08-30T10:13Z [----] followers, 505.5K engagements

"🚨New ASCO Guidelines have been published ASCO's Expert Panel has developed comprehensive recommendations for systemic therapy in metastatic #GEP-NETs. Discover the latest insights and strategies for patient care. #MedED https://ow.ly/WQUi50PRGKb https://ow.ly/WQUi50PRGKb"
X Link 2023-10-02T07:43Z [----] followers, [----] engagements

"💡Spotlighting the diversity in pancreatic cancers on #PancreaticCancerDay: adenocarcinomas (90%) and the lesser-known pancreatic #NETs. Understanding the difference matters. Explore our educational programme for insights and awareness. #MedEd https://ow.ly/Qhmu50Q766o https://ow.ly/Qhmu50Q766o"
X Link 2023-11-16T10:00Z [----] followers, [---] engagements

"🔬 PRRT shows promise for high-grade digestive NENs including #NET G3 with strong PFS benefits in recent studies like NETTER-2. Could this be a 1st-line option For NEC evidence is limited but PRRT may be considered in select cases. #MedEd https://ow.ly/par850TjO8Z https://ow.ly/par850TjO8Z"
X Link 2024-09-10T09:29Z [----] followers, [----] engagements

"Dr. Elettra Merola and Dr. Kira Oleinikov have summarised highlights of the recent #ENETS19 for you @ @net_connectinfo #NETCancer #NeuroendocrineCancer #NeuroendocrineTumors https://net-connect.info/update-from-enets-2019/ https://net-connect.info/update-from-enets-2019/"
X Link 2019-03-14T18:20Z [----] followers, [--] engagements

"An interactive discussion on treatment sequencing in advanced digestive NETs. Thanks to the esteemed faculty of Dr. Marianne Pavel Dr. Jaume Capdevila (@Ja_Capdevila) Dr. Louis DeMestier (@louis_demestier) and Dr. Angela Lamarca. Thank you to all attendees for participating"
X Link 2019-09-30T07:11Z [----] followers, [--] engagements

"Dr. Angela Lamarca on behalf of @net_connectinfo discusses the highlights on neuroendocrine tumours presented at #ESMO19 @ #neuroendocrine #NETCancer #NeuroendocrineCancer #NeuroendocrineTumors https://net-connect.info/net-connect-update-from-esmo-2019/ https://net-connect.info/net-connect-update-from-esmo-2019/"
X Link 2019-10-09T09:39Z [----] followers, [--] engagements

"Interested in learning more about practice changing clinical trials in #NeuroendocrineTumors Explore this resource developed by Dr Joakim Crona (@CronaJoakim) on behalf of @net_connectinfo #NETCancer #education #oncology https://net-connect.info/practice-changing-clinical-trials-in-net/ https://net-connect.info/practice-changing-clinical-trials-in-net/"
X Link 2019-11-14T14:25Z [----] followers, [--] engagements

"Learn about Treatment Sequencing in Advanced Digestive NET an accredited e-learning with @net_connectinfo members Prof. Pavel @Ja_Capdevila @louis_demestier and Dr. Angela Lamarca #NETCancer #NeuroendocrineCancer #oncology https://net-connect.info/e-learning-treatment-sequencing-in-advanced-digestive-net/ https://net-connect.info/e-learning-treatment-sequencing-in-advanced-digestive-net/"
X Link 2020-01-27T09:04Z [----] followers, [--] engagements

"Fantastic start to #ENETS2020 well done to all involved; a great opportunity to collaborate virtually. Looking forward to the next few days"
X Link 2020-03-11T11:29Z [----] followers, [--] engagements

"Listen to the results of [--] @net_connectinfo studies from #ENETS20 on SSAs in pNETs (Ki-67 10%) Management of advanced digestive G3 NETs & Management of CHD in advanced midgut NET at #NETCancer #NeuroendocrineCancer #oncology #MedEd https://net-connect.info/net-connect-scientific-projects-presented-at-enets-2020/ https://net-connect.info/net-connect-scientific-projects-presented-at-enets-2020/"
X Link 2020-05-20T16:17Z [----] followers, [--] engagements

"Great to hear from @cives_mauro at #ESMO22 on the results of an international NET CONNECT survey looking at the impact of COVID-19 on the management of NETs.coming soon #NET"
X Link 2022-09-12T13:10Z [----] followers, [--] engagements

"📅The first #ENETS webinar of [----] will take place on [--] Jan this time moderated by our @net_connectinfo expert @DrAngelaLamarca Topic: Where do we stand in #NET #NEC #PPGL #MTC & #MCC 👉🏼 #MedEd http://ow.ly/OSYi50MkVAT http://ow.ly/OSYi50MkVAT"
X Link 2023-01-17T08:50Z [----] followers, [----] engagements

"@T_AlonsoGordoa provides an update on PRRT in GI-NET on behalf of @net_connectinfo @ #NETCancer #NeuroendocrineCancer #NeuroendocrineTumors https://net-connect.info/prrt-in-gi-net/ https://net-connect.info/prrt-in-gi-net/"
X Link 2019-04-10T21:14Z [----] followers, [--] engagements

"Dr. Aman Chauhan @AmanChauhanMD (on behalf of @net_connectinfo) provides highlights on neuroendocrine tumours presented at #ASCO19 and #AACR19 @ #neuroendocrine #NETCancer #NeuroendocrineCancer #NeuroendocrineTumors http://bit.ly/2RbtxXz http://bit.ly/2RbtxXz"
X Link 2019-06-12T15:44Z [----] followers, [--] engagements

"Oral NET abstract at #WorldGI2020 on germline mutations in young #NET patients presented by Prof Riechelmann.#MedEd #oncology"
X Link 2020-07-02T22:16Z [----] followers, [--] engagements

"NGS practice patterns Another interesting project being initiated within the NETCONNECT group #NET #Oncology #MedEd t-NET [--] Mitosis/10HPF and Ki67 40%.Morphology intermediate: LCNEC-atypical carcinoid.TMB 23Pt qualifed for our immuno trial.We at @net_connectinfo studying NGS practice pattern in NETs globally. Do u use NGS for NETs/NEC Upfront or Relapse Trials or SOC @pashtoonkasi https://t.co/bKXX0fCWjb t-NET [--] Mitosis/10HPF and Ki67 40%.Morphology intermediate: LCNEC-atypical carcinoid.TMB 23Pt qualifed for our immuno trial.We at @net_connectinfo studying NGS practice pattern in NETs"
X Link 2020-07-12T09:05Z [----] followers, [--] engagements

"What is the role of nuclear medicine in the management of NENs Several NET CONNECT members contributed to this international consensus on molecular imaging and theranostics in NENs. @Ja_Capdevila #NET #NETCancer #NeuroEndocrineCancer #MedEd #oncology http://ow.ly/j2qH50DV7Db http://ow.ly/j2qH50DV7Db"
X Link 2021-03-12T11:25Z [----] followers, [--] engagements

"Two sessions on RAI-R differentiated thyroid cancer: 👉 @Ja_Capdevila presented COSMIC-311 showing a superior efficacy of cabozantinib treatment vs. placebo. 👉 Sophie Leboulleux presents results from the MERAIODE trial with trametinib in RAS-mutated patients. #ESMO21 #MedEd"
X Link 2021-09-20T17:04Z [----] followers, [--] engagements

"🎙New episode of our PODCAST 🎙 Listen to Prof. Martyn Caplin & Dr Aman Chauhan @AmanChauhanMD as they discuss the role of SSAs in #NETs at progression sharing their clinical experience and their own practice Tune in learn and share: #MedEd https://cor2ed.com/net-connect/programmes/podcast-the-role-of-ssa-at-progression-to-continue-or-not/ https://cor2ed.com/net-connect/programmes/podcast-the-role-of-ssa-at-progression-to-continue-or-not/"
X Link 2022-11-22T14:57Z [----] followers, [--] engagements

"Update for advanced NET patients with 177Lu-DOTATATE retreatment 📊 Median PFS: [----] mos post-initial; [---] mos post-retreatment. Median OS: [----] mos post-initial; [----] mos post-retreatment. 35% showed partial response initially; 23% post-retreatment. https://ow.ly/LVOB50R0UaT https://ow.ly/LVOB50R0UaT"
X Link 2024-03-25T10:46Z [----] followers, [----] engagements

"💡New scoping review investigates #PRRT as neoadjuvant therapy in #NeuroendocrineNeoplasms. Limited evidence suggests potential role in enhancing resectability yet high-quality studies are needed to confirm benefits and optimize protocols. #MedEd https://ow.ly/uEUx50Sss5j https://ow.ly/uEUx50Sss5j"
X Link 2024-07-03T08:01Z [----] followers, [---] engagements

"Dr. Francesca Spada provides an overview of #CarcinoidSyndrome on behalf of @net_connectinfo @ #neuroendocrine #NETCancer #NeuroendocrineCancer #NeuroendocrineTumors https://net-connect.info/an-overview-of-carcinoid-syndrome/ https://net-connect.info/an-overview-of-carcinoid-syndrome/"
X Link 2019-05-15T20:16Z [----] followers, [--] engagements

"Congratulations Dr Capdevila @Ja_Capdevila on this role Felicidades al Dr Capdevila (@Ja_Capdevila) de @vallhebron @VHIO nuevo presidente de @GrupoGetne Le deseamos muchos xitos con a la nueva junta directiva. Tambin un enorme agradecimiento a la Dra Garcia Carbonero por su etapa como presidenta dejando muy alto el listn. https://t.co/CiJZJZBhYW Felicidades al Dr Capdevila (@Ja_Capdevila) de @vallhebron @VHIO nuevo presidente de @GrupoGetne Le deseamos muchos xitos con a la nueva junta directiva. Tambin un enorme agradecimiento a la Dra Garcia Carbonero por su etapa como presidenta dejando"
X Link 2019-09-26T12:12Z [----] followers, [--] engagements

"Understand more about treatment sequencing in advanced digestive NET from a recent @net_connectinfo Experts Knowledge Share with @Ja_Capdevila @louis_demestier Prof Marianne Pavel and Dr Angela Lamarca #NETCancer #NeuroendocrineCancer #oncology visit: https://net-connect.info/net-connect-eks-esmo-2019/ https://net-connect.info/net-connect-eks-esmo-2019/"
X Link 2019-11-06T18:35Z [----] followers, [--] engagements

"Interesting presentation on 'Assessing Response to PRRT' today during #ENETS2020. Looking forward to the rest of the day [--] of the ENETS virtual meeting"
X Link 2020-03-12T12:45Z [----] followers, [--] engagements

"An update from the first virtual #ENETS20 conference is now available summarised by Dr. Alia Munir and Dr. Mauro Cives on behalf of NET CONNECT. Videos and downloadable slides @ #NETCancer #NeuroendocrineCancer #oncology #MedEd https://net-connect.info/net-connect-update-from-enets-2020/ https://net-connect.info/net-connect-update-from-enets-2020/"
X Link 2020-03-20T17:13Z [----] followers, [--] engagements

"Results of [--] @net_connectinfo studies from #ENETS20 on SSAs in pNETs (Ki-67 10%) Management of advanced digestive G3 NETs & Management of CHD in advanced midgut NET summarised by @T_AlonsoGordoa @louis_demestier & Dr Faidon Laskaratos https://net-connect.info/net-connect-scientific-projects-presented-at-enets-2020/ https://net-connect.info/net-connect-scientific-projects-presented-at-enets-2020/"
X Link 2020-05-07T12:44Z [----] followers, [--] engagements

"Interesting early data of nivolumab and temizolomide in advanced NETs. #NET #oncology #MedEd"
X Link 2020-05-20T12:10Z [----] followers, [--] engagements

"Congratulations to Val DHebron and one of our esteemed NET Connect steering committee: @Ja_Capdevila First center of excellence for NET treatment in Spain. Hospital Universitari Vall dHebron together with VHIO have recently been accredited as Centre of Excellence by ENETS. Congratulations to the whole team @Netespana #LetsTalkAboutNETs https://t.co/k0qiH3qxNU First center of excellence for NET treatment in Spain. Hospital Universitari Vall dHebron together with VHIO have recently been accredited as Centre of Excellence by ENETS. Congratulations to the whole team @Netespana #LetsTalkAboutNETs"
X Link 2020-06-24T15:56Z [----] followers, [--] engagements

"NET highlights from the recent virtual #ASCO20 #AACR20 and #WCGIC20 meetings summarised by @AmanChauhanMD on behalf of NET CONNECT. Video and downloadable slides available at #NETCancer #NeuroendocrineCancer #oncology #MedEd https://net-connect.info/net-connect-update-from-asco-aacr-and-wcgic-2020/ https://net-connect.info/net-connect-update-from-asco-aacr-and-wcgic-2020/"
X Link 2020-07-16T21:53Z [----] followers, [--] engagements

"Good selection of NET mini oral sessions at #ESMO20. CLARINET FORTE presentation by Marianne Pavel providing encouraging data on escalating lanreotide dose frequency followed by interesting discussant by Angela Lamarca indicating difficult to compare with studies like NETTER-1"
X Link 2020-09-19T22:46Z [----] followers, [--] engagements

"DUNE study presented by @Ja_Capdevila #ESMO20 durvalumab+tremelimumab showed only modest activity in a heavily pretreated group of advanced NENs. GEP-NEN cohort data promising #NET #Oncology #MedEd"
X Link 2020-09-20T22:46Z [----] followers, [--] engagements

"On NET cancer day NET CONNECT is proud to play our part in raising awareness of #NET and providing medical education programs in this rare disease area.#MedEd #Onc"
X Link 2020-11-10T06:46Z [----] followers, [--] engagements

"Delighted @net_connectinfo members have had [--] abstracts accepted for poster presentations at #ENETS21. Watch out for abstracts on NGS practice patterns and 3rd line treatment practice for wd-SiNET @T_AlonsoGordoa @louis_demestier @AmanChauhanMD @CronaJoakim #MedEd #Oncology #NET"
X Link 2021-01-13T22:59Z [----] followers, [--] engagements

"Presentation on the first study of circulating progastrin (hPG80) in #NET by NET Connect member @AmanChauhanMD showing hPG80 as a promising biomarker. #ENETS21 #ENETS2021 #Oncology #MedEd"
X Link 2021-02-25T14:58Z [----] followers, [--] engagements

"Small intestine well-differentiated NETs: what is the current practice and rationale for 3rd line treatment after SSA and PRRT Check out the poster presentation of our NET CONNECT members at #ENETS21. #ENETS2021 #NET #MedEd #oncology"
X Link 2021-02-25T16:18Z [----] followers, [--] engagements

"PRRT treatment in #NET: A great overview of improved peptides for PRRT other targets for PRRT new radionuclides and combination therapies with PRRT presented by Prof. Damian Wild during #ENETS21. #ENETS2021 #MedEd #oncology"
X Link 2021-02-26T12:24Z [----] followers, [--] engagements

"Many ongoing clinical trials in Europe North America Asia and Australia. A great overview of this was given by @drenriquegrande NET connect member Emily Bergsland and Jie Chen. #ENETS21 #ENETS2021 #NET #MedEd #oncology"
X Link 2021-02-26T15:23Z [----] followers, [--] engagements

"Great session on Translational Research with two different presentations on the use of organoid models in NEN. @TalyaDalton and Dr. Kenta Kawasaki. #NETs 'ENETS21 #ENETS2021 #Oncology #MedEd"
X Link 2021-02-26T16:54Z [----] followers, [--] engagements

"Immunotherapy in lung NEN: NET CONNECT member @Ja_Capdevila gave a great overview of immunotherapy in lung NEN and the ongoing clinical trials in this field. #ENETS21 #ENETS2021 #NET #MedEd #oncology"
X Link 2021-02-27T16:27Z [----] followers, [--] engagements

"As presented by @drenriquegrande during #ENETS2021: an overview of ongoing clinical trials in Europe. #NET #NETCancer #NeuroEndocrineCancer #MedEd #oncology https://x.com/ncukcharity/status/1366392977862623234 Clinical Trials - Enrique Grandes whistlestop tour of Europe: https://t.co/D3r1CDABBm listed as recruiting/not yet recruiting : ARTISAN BEVANEC CABATEN CABONEN COMPETE DUNE FOLFIRINEC LUTHREE LOLA MGMT-NET NEONEC NIPINEC SENECA #ENETs2021 https://x.com/ncukcharity/status/1366392977862623234 Clinical Trials - Enrique Grandes whistlestop tour of Europe: https://t.co/D3r1CDABBm listed as"
X Link 2021-03-09T10:29Z [----] followers, [--] engagements

"On March 28th NET CONNECT member @AmanChauhanMD will give a presentation at the Advances in Gastrointestinal Cancer International Conference and talk about #PRRT in #NETs. #NETCancer #MedEd #oncology https://x.com/btfoundation/status/1372589866525941761 We are holding our virtual #GIcancer #GISM conference for #CME on March [--] Attend to hear talks on recent clinical advancements from national and global experts including @SirohiBhawna @AmanChauhanMD @DocCatenacci and more Register to attend at https://t.co/Dfhvujkx3D https://t.co/LRzh1Kw3Xi"
X Link 2021-03-24T11:38Z [----] followers, [--] engagements

"Poster [---] at #AACR21: NET CONNECT member @AmanChauhanMD and colleagues present the phase [--] trial of triapine and Lutetium Lu [---] Dotatate in combination for well-differentiated somatostatin receptor-positive GEP-NETs. #NET #NETCancer #MedEd #oncology https://x.com/NCICTEP_ClinRes/status/1380856855593938952 https://x.com/NCICTEP_ClinRes/status/1380856855593938952"
X Link 2021-04-11T15:51Z [----] followers, [--] engagements

"Poster [---] at #AACR21: Important preclinical research by @3amrogram and colleagues on the efficacy of platinum based chemotherapy regimens and targeted therapeutics in a PDX model of mixed acinar neuroendocrine carcinoma of the pancreas (MANEC-P). #MedEd http://ow.ly/XooJ50EozvV http://ow.ly/XooJ50EozvV"
X Link 2021-04-14T21:04Z [----] followers, [--] engagements

"Great work by @Ja_Capdevila and colleagues on the TALENT phase II trial showing very promising results for the use of lenvatinib in advanced GEP-NETs. #NET #NETCancer #MedEd https://x.com/Ja_Capdevila/status/1389861184942313479 TALENT study publication arrives on May the 4th 🌟😬💪🏼One of the highest response rate ever seen in #NeuroendocrineCancer with an MKI @drenriquegrande @JHernando3 @PaulaJFonseca @xavimerino @lorenatrejo91 @GrupoGetne @Netespana @VHIO @_SEOM @vallhebron https://t.co/Ouu3veJl2n https://x.com/Ja_Capdevila/status/1389861184942313479 TALENT study publication arrives on"
X Link 2021-05-05T10:41Z [----] followers, [--] engagements

"#ASCO21: The NETTER-1 study shows positive final results on PFS after 177Lu-DOTATATE treatment in #NET. To aid consideration of #PRRT with 177Lu-DOTATATE @nanudasmd and colleagues developed and validated a clinical score. http://ow.ly/qeOI50F3WL8 http://ow.ly/OEOp50F3NHc http://ow.ly/qeOI50F3WL8 http://ow.ly/OEOp50F3NHc"
X Link 2021-06-06T16:55Z [----] followers, [--] engagements

"At #WorldGI2021 Jonathan Strosberg discussed the results from the NETTER-1 study: Significant improvement in PFS Trend of improvement in median OS (11.7 months) in 177Lu-DOTATATE vs control No new long-term safety signals for MDS and nephrotoxicity #NET #MedEd"
X Link 2021-07-04T22:29Z [----] followers, [--] engagements

"A recent publication by NET CONNECT steering committee member Prof. Kjell berg and his colleagues showed that a multigenomic blood biomarker (#NETest) effectively diagnoses #NETs and outperforms CgA. #NeuroEndocrineTumors #MedEd https://x.com/myESMO/status/1427662076391133192 A blood-based #multigenomic signature is an effective diagnostic & has clinical utility in #NET mgmt: the 51-gene expression-based #liquidbiopsy accurately diagnoses #neuroendocrinetumours & is an effective surrogate marker compared to chromogranin A https://t.co/iq1Z4vTIpG https://t.co/VX7OtB4YFr"
X Link 2021-08-19T11:58Z [----] followers, [--] engagements

"Podcast now available Listen to Dr Jaume Capdevila @Ja_Capdevila and Dr Rachel van Leeuwaarde discuss Optimal Management of #DifferentiatedThyroidCancer with VEGFR-TKIs (MKIs) #thyroidcancerawarenessmonth #ThyCa Access the podcast here https://net-connect.info/podcast-optimising-vegfr-tkis-mkis-in-differentiated-thyroid-cancer/ https://net-connect.info/podcast-optimising-vegfr-tkis-mkis-in-differentiated-thyroid-cancer/"
X Link 2021-09-09T10:35Z [----] followers, [--] engagements

"Listen to our podcast with Dr Jaume Capdevila @Ja_Capdevila and Dr Rachel van Leeuwaarde talking about Optimal Management of #DifferentiatedThyroidCancer with VEGFR-TKIs (MKIs) #ThyCa Access the podcast here https://net-connect.info/podcast-optimising-vegfr-tkis-mkis-in-differentiated-thyroid-cancer/ https://net-connect.info/podcast-optimising-vegfr-tkis-mkis-in-differentiated-thyroid-cancer/"
X Link 2021-10-05T20:25Z [----] followers, [--] engagements

"Great presentation by @Ja_Capdevila on the efficacy of lanreotide in patients with metastatic BP-NETs (the SPINET study) emphasizing that tumor growth rate (TGR) is a promising exploratory endpoint and should be included in future clinical trials. #ENETS22 #ENETS #MedEd"
X Link 2022-03-10T11:22Z [----] followers, [--] engagements

"Results from the MetNET-2 trial presented by Sara Pusceddu suggest a synergistic activity between lanreotide and metformin which requires further investigation in RCTs. Genomic characterization of #NETs may help elucidate mechanisms underlying this. #ENETS22 #ENETS #MedEd"
X Link 2022-03-10T17:43Z [----] followers, [--] engagements

"Maria del Carmen Riesco-Martinez presented the results from the NICE-NEC study on nivolumab and platinum-doublet chemotherapy in untreated advanced G3 NENs showing a synergistic effect which requires further follow-up and RCTs. @GrupoGetne #ENETS22 #ENETS #MedEd"
X Link 2022-03-11T17:47Z [----] followers, [--] engagements

"What are best treatment sequences in advanced NET In the next #ENETS webinar this will be discussed for lung NET PNET and SiNET by Dieter Hrsch @Ja_Capdevila and @RachelRiechelm2 . #MedEd #NeuroEndocrineTumor http://ow.ly/2VVb50INaML http://ow.ly/2VVb50INaML"
X Link 2022-04-25T08:00Z [----] followers, [--] engagements

"#ENETS have recently published a new guideline for Carcinoid Syndrome and Carcinoid Heart Disease: Additional recommendation for standardised reporting of #NETs has also been issued by the #ENETS experts: 👉 #MedEd #NET http://ow.ly/mES250JeiaC http://ow.ly/glvH50Jei9P http://ow.ly/mES250JeiaC http://ow.ly/glvH50Jei9P"
X Link 2022-05-26T08:00Z [----] followers, [--] engagements

"With #ASCO2022 just around the corner we will be providing social media coverage on the most important developments in #NET. Tag along as Dr. @PamelaKunzMD presents the final efficacy analysis of #MGMT as a predictive biomarker on June [--] 14:48 BST. http://ow.ly/NHbc50Jk9Wx http://ow.ly/NHbc50Jk9Wx"
X Link 2022-05-30T11:00Z [----] followers, [--] engagements

"Which patients to treat and when to start PRRT therapy in #NETs This review article @JCO_ASCO provides guidance on patient selection and treatment strategy using #PRRT. Great to see our experts Dr. Marianne Pavel and Dr. Emily Bergsland as authors http://ow.ly/XwEM50JNKhj http://ow.ly/XwEM50JNKhj"
X Link 2022-07-05T08:00Z [----] followers, [--] engagements

"⚡ Results of the Phase [--] #TOPIC-NEC trial published in @JAMAOnc Study finds that both #etoposide plus #cisplatin (EP) or #irinotecan plus cisplatin (IP) remain effective 1L treatments for pts with advanced #NEC of the digestive system. #MedEd http://ow.ly/RXo350KnY5O http://ow.ly/RXo350KnY5O"
X Link 2022-08-22T07:00Z [----] followers, [--] engagements

"Knowing your patients symptoms can save their lives #LetsTalkAboutNETs #MedEd #NETs https://x.com/ncukcharity/status/1565256975486705664 For #GPs Could it be Neuroendocrine Cancer If you have patients returning with unresolved and / or increasing symptoms Neuroendocrine Cancer may be worth considering: @rcgp @UKINETS https://t.co/MqLJeyymy6 https://x.com/ncukcharity/status/1565256975486705664 For #GPs Could it be Neuroendocrine Cancer If you have patients returning with unresolved and / or increasing symptoms Neuroendocrine Cancer may be worth considering: @rcgp @UKINETS"
X Link 2022-09-04T10:16Z [----] followers, [--] engagements

"Effects of the COVID-19 pandemic on NET management published in @JNE_Editor. Thanks to the authors @cives_mauro @JHernando3 @DrAngelaLamarca Catherine Bouvier Ellis @ncukcharity @Prof_M_C Prof Pavel. Thanks also to INCA & @NANETS1 #LetsTalkAboutNETs https://cor2ed.com/net-connect/programmes/international-net-covid-19-survey-published-in-journal-of-neuroendocrinology/ https://cor2ed.com/net-connect/programmes/international-net-covid-19-survey-published-in-journal-of-neuroendocrinology/"
X Link 2022-10-17T14:34Z [----] followers, [---] engagements

"Delighted to announce we have launched the #NET micro e-learning on the role of SSA at progression developed by Prof. Caplin & @AmanChauhanMD 🔴slides flashcard & podcast available 🔴test your knowledge with the assessment 🔴accredited course #MedEd http://ow.ly/vwK850M6OQp http://ow.ly/vwK850M6OQp"
X Link 2022-12-20T16:23Z [----] followers, 836.7K engagements

"Global #SCAN survey of #NET pts finds among [----] pts in [----] 44% were misdiagnosed & the mean years to correct diagnosis is [---] years Enhancing #HCP knowledge & effective diagnostics are key to improved pts survival & #NET care worldwide. #MedEd https://ow.ly/gVZP50OZFqb https://ow.ly/gVZP50OZFqb"
X Link 2023-07-04T08:00Z [----] followers, [----] engagements

"🎧 Did you tune into the podcast with Prof. Martyn Caplin & Dr Aman Chauhan They discuss the role of SSAs in #NETs at progression sharing their own experience and clinical practice. Listen on your preferred podcast platform: Spotify: Apple: COR2ED Website: Don't miss it #MedEd https://shorturl.at/ehjD7 https://shorturl.at/sFOW9 https://shorturl.at/dpNV6 https://shorturl.at/ehjD7 https://shorturl.at/sFOW9 https://shorturl.at/dpNV6"
X Link 2023-09-18T14:26Z [----] followers, 681K engagements

"📚Explore the world of #NETs Join Dr @Ja_Capdevila & Asst. Prof. @cives_mauro in this insightful micro-learning module & learn to recognise symptoms diagnose accurately & manage effectively. 👉Check it out today: #MedEd https://ow.ly/kXT950PUmV2 https://ow.ly/kXT950PUmV2"
X Link 2023-10-11T09:01Z [----] followers, [---] engagements

"🚨⚡New guidelines for management of #NF-Pan-NET published Specialists worked together to answer [--] troublesome clinical questions such as: 💡What is the role of PRRT in pts w/ NF-Pan-NET 💡What is the recommended follow-up in NF-Pan-NET pts https://ow.ly/VVje50Q5Yrk https://ow.ly/VVje50Q5Yrk"
X Link 2023-11-10T11:54Z [----] followers, [---] engagements

"💡On #NETCancerDay let's amplify the importance of independent medical education in understanding & addressing #NETs. Knowledge empowers & today we unite for awareness support & continued education to improve outcomes for NET patients. Follow us for more #MedEd content"
X Link 2023-11-10T11:55Z [----] followers, [---] engagements

"💭#PanNETS are rare & complicated pancreatic cancers with various subtypes genetic pathways familial syndromes biomarkers hormones imaging & more Explore the molecular pathogenesis diagnosis & treatment in this comprehensive review: #MedEd https://ow.ly/qLGp50QcAGs https://ow.ly/qLGp50QcAGs"
X Link 2023-11-29T19:03Z [----] followers, [---] engagements

"A retrospective analysis on #PRRT for #NET reveals extending treatment beyond the standard [--] cycles may offer a safe & effective strategy. 📊 More cycles linked to better overall survival (72.8 months vs. [----] months) & disease-specific survival. #MedEd https://ow.ly/Ll4o50QgiPX https://ow.ly/Ll4o50QgiPX"
X Link 2023-12-11T14:50Z [----] followers, [----] engagements

"New study explores therapeutic options for high-grade #GEP-NENs using patient-derived tumoroids. 📊Findings reveal their ability to mirror clinical responses to chemotherapy ex vivo potentially advancing personalised treatment options. #MedEd https://ow.ly/fJtY50QKzVp https://ow.ly/fJtY50QKzVp"
X Link 2024-03-08T09:01Z [----] followers, [---] engagements

"👏 NET CONNECT expert @louis_demestier shared invaluable insights on Familial Midgut Neuroendocrine Tumors (#FM-NETs) at #ENETS2024 https://x.com/JHernando3/status/1767891925519007993s=20 @louis_demestier presents data regarding familial midgut NETs. An interesting entity probably under-suspected in our clinical practice. Molecular testing still ongoing. #ENETS24 #ENETS2024 🦓🦓🦓 https://t.co/uyS2oxy6N5 https://x.com/JHernando3/status/1767891925519007993s=20 @louis_demestier presents data regarding familial midgut NETs. An interesting entity probably under-suspected in our clinical practice."
X Link 2024-03-14T08:04Z [----] followers, [---] engagements

"Exciting news from #ESMOSarcomaCongress2024: Lurbinectedin & irinotecan combo demonstrates synergy in pre-treated Grade [--] GEP-NECs Phase II study reports ORR of 15% DCR of 60% median PFS of [---] months & OS at [--] months of 45.0%. #MedEd https://ow.ly/e0gY50QVc2E https://ow.ly/e0gY50QVc2E"
X Link 2024-03-18T07:04Z [----] followers, [----] engagements

"Tumour size (2cm) & grade (G2 G3) emerge as significant risk factors for lymph node metastasis in #NETs and should be considered when selecting a treatment option for radical resection with #LN dissection for rectal NETs a recent study reports. https://ow.ly/RJmM50RjKKq https://ow.ly/RJmM50RjKKq"
X Link 2024-04-22T16:03Z [----] followers, [----] engagements

"🔬DOTATATE-PET CT for #GEP-NETs: Larger tumours (2 cm) higher CgA levels (150 ng/mL) and higher tumour grades (G2) are significant predictors. Tumour size OR: [-----] (P0.001) CgA OR: [----] (P=0.005) grade G2 OR: [---] (P0.001). #MedEd https://ow.ly/MpeM50SnV1o https://ow.ly/MpeM50SnV1o"
X Link 2024-06-24T08:04Z [----] followers, [---] engagements

"🌍🔬 The [----] ENETS guidance paper for managing well-differentiated small intestine neuroendocrine tumours (#Si-NET) is out It emphasises the importance of adequate biochemical assessment staging and multidisciplinary treatment decisions. #MedEd https://ow.ly/USu150Syga9 https://ow.ly/USu150Syga9"
X Link 2024-07-10T03:44Z [----] followers, [---] engagements

"🔥It's out now 📺Dive into our free #MedED resource created with Prof. Emily Bergsland & Asst Prof. Louis de Mestier with tools for optimising advanced #NETs treatment & management. Explore key tumour patient and treatment factors. Check it out now https://cor2ed.com/net-connect/programmes/treatment-management-advanced-nets/ https://cor2ed.com/net-connect/programmes/treatment-management-advanced-nets/"
X Link 2024-07-31T14:51Z [----] followers, 672.3K engagements

"📊 In the LUTADOSE study tumour dosimetry after 1st administration of 177Lu-DOTATATE had prognostic value in patients with G1-G2 GEP NETs. Higher GTD after cycle [--] (10.6 Gy) correlated with longer PFS (median [----] vs. [--] months) #MedEd https://ow.ly/KOJY50TjQWZ https://ow.ly/KOJY50TjQWZ"
X Link 2024-09-12T08:01Z [----] followers, [---] engagements

"🗣Insightful discussions on #NETs are unfolding at #ESMO2024 in Barcelona We're excited to learn about the latest developments. Follow us to stay in the loop https://x.com/FRANCES88189587/status/1834718750698090504 📣📣📣The best way to start ESMO2024 for neuroendocrine community Amazing session brilliant speakers vibrant discussions. Lovely friends and colleagues and more 🚨CMV-118 in progressive NET 🚨CABONEN in low G3 NEN 🚨NETTER-2 and new insights 🚨Carcinoid heart disease and NET https://t.co/SVuF8pJds6 https://x.com/FRANCES88189587/status/1834718750698090504 📣📣📣The best way to start"
X Link 2024-09-15T04:33Z [----] followers, [---] engagements

"#ESMO24 I ABS1148MO 🔥📊NETTER-2 update: 177Lu-DOTATATE + octreotide 30mg LAR shows PFS HR [-----] (95% CI: 0.134-0.337) vs high-dose octreotide (0.276) ORR odds ratio [-----] (95% CI: 3.98-27.29) vs [----]. No new safety concerns. Is this a new standard of care #MedEd"
X Link 2024-09-15T04:44Z [----] followers, [---] engagements

"🔥It's out now 📢 Check out our new 2-part podcast series on #NETs In Ep. [--] @DrMohidKhan & patient advocate Sally Jenkins discuss shared decision-making. Ep. [--] explores how to individualise treatment decisions for better patient outcomes. #MedEd https://ow.ly/h8jU50ToEUK https://ow.ly/h8jU50ToEUK"
X Link 2024-09-24T19:12Z [----] followers, 282.8K engagements

"🔥 New guidelines Managing rare endocrine tumours such as #neuroendocrine neoplasms & parathyroid carcinoma from diagnosis to follow-up. Expert insights from global experts including @net_connectinfo Member @DrAngelaLamarca #MedEd https://x.com/myESMO/status/1841045187176411420 📣 New ESMO #ClinicalPracticeGuideline on Rare #EndocrineTumors: Evidence-based recommendations on imaging diagnosis treatment & follow-up of neuroendocrine parathyroid and intrathyroid thymic neoplasms by experts across Europe. #RareTumors 🔗 https://t.co/c3lFb7icrX https://t.co/cwVyf4wGEM"
X Link 2024-10-07T11:59Z [----] followers, [---] engagements

"New practice guideline alert📢 #Si-NET cases are rising often found late. This new guidance paper from @net_connectinfo Expert @DrAngelaLamarca covers key points on diagnosis staging and treatment in specialised centres. Read more: #MedEd https://ow.ly/wYvj50TN9Iz https://ow.ly/wYvj50TN9Iz"
X Link 2024-10-18T08:00Z [----] followers, [---] engagements

"📺 Explore our free #MedED resource developed by Prof. Emily Bergsland and Prof. Louis de Mestier. With practical tools for optimising advanced #NETs treatment and management focusing on key tumour patient and treatment factors. Discover it today https://cor2ed.com/net-connect/programmes/treatment-management-advanced-nets/ https://cor2ed.com/net-connect/programmes/treatment-management-advanced-nets/"
X Link 2024-12-10T11:45Z [----] followers, 75.4K engagements

"Did you catch our recent podcast series In Ep.1 Dr Mohid Khan & patient advocate Sally Jenkins discuss shared decision-making and in Ep. [--] they explore how to individualise treatment decisions for better patient outcomes. #LetsTalkAboutNETs Take a look at the highlights📹 Full video at 👉 Supported by an #IME grant from Ipsen #MedEd https://cor2ed.com/net-connect/programmes/net-shared-decision-making/ https://cor2ed.com/net-connect/programmes/net-shared-decision-making/"
X Link 2025-02-06T22:58Z [----] followers, 459.9K engagements

"New podcast Expert perspectives on PRRT and emerging strategies in NETs 📹 Explore diagnostic strategies pt selection based on clinical trials safety profiles/AE mgmt future directions & more w/ Dr @helops79 @ProfKHerrmann @OncBrothers Endorsed by @NANETS1 CommNETs (@GICancer)@ncukcharity Supported by an Independent Educational Grant from ITM"
X Link 2025-10-02T21:21Z [----] followers, 1.9M engagements

"Raising awareness for World Neuroendocrine Cancer Day Understanding EP-NEC: Through diagnosis treatment and support What do the differences between NETs and NECs mean for patients Poorly differentiated high-grade aggressive cancers need urgent treatment options. Find out more in this video podcast w/ Medical Oncologist Dr @AmanChauhanMD & Neuroendocrine Patient Advocate Susan Meckler-Plummer RN 📹 Highlights in this post Endorsed by Minkahz NETs Mission @ncukcharity @NCFCancer and @CureNETs For more information or support please speak with an HCP or reach out to a local patient advocacy group"
X Link 2025-11-11T09:16Z [----] followers, 373.2K engagements

"Thriving beyond an EP-NEC diagnosis: new video Extra-pulmonary neuroendocrine carcinoma (EP-NEC) is rare aggressive & often misunderstood/ diagnosed late This video explores: -EP-NEC in context -The complexity and burden of the disease -The concept of thrivership 📺 w/ Jessica Thomas Director of Patient Education at the Neuroendocrine Tumor Research Foundation Endorsed by @CureNETs & Minkahz NETs Mission Supported by an Independent Educational Grant from Boehringer Ingelheim"
X Link 2025-12-28T18:46Z [----] followers, 563.6K engagements

"Thriving beyond an EP-NEC diagnosis: Perspectives on treatment and care 📺Video for patients & HCPs From Jessica Thomas Director of Patient Education at the Neuroendocrine Tumor Research Foundation 🤝 Endorsed by @CureNETs & Minkahz NETs Mission See more of this programme: Supported by an Independent Educational Grant from Boehringer Ingelheim #MedEd #OncTwitter https://cor2ed.com/net-connect/programmes/thriving-beyond-ep-nec-diagnosis/ https://cor2ed.com/net-connect/programmes/thriving-beyond-ep-nec-diagnosis/"
X Link 2026-01-02T13:15Z [----] followers, [---] engagements

"➡ EP-NEC patients require expert care from specialists knowledgeable in #neuroendocrine carcinoma ➡ Generic care is insufficient to address the aggressive nature and unique challenges of this disease What else do HCPs need to know to support pts w/ extrapulmonary neuroendocrine carcinoma 📺 Watch the video to find out From Jessica Thomas Director of Patient Education at the Neuroendocrine Tumor Research Foundation 🤝 Endorsed by @CureNETs & Minkahz NETs Mission See more of this programme: Supported by an Independent Educational Grant from Boehringer Ingelheim #MedEd #OncTwitter"
X Link 2026-01-09T17:09Z [----] followers, [---] engagements

"Understanding EP-NEC: Through diagnosis treatment and support What do the differences between NETs and NECs mean for patients Poorly differentiated high-grade aggressive cancers need urgent treatment options. Find out more in this video podcast 🎙 w/ Medical Oncologist @AmanChauhanMD & Neuroendocrine Patient Advocate Susan Meckler-Plummer RN 📹 Highlights in this post Watch the full video or listen on Spotify/Apple: 🤝 Endorsed by Minkahz NETs Mission @ncukcharity @NCFCancer and @CureNETs For more information or support please speak with an HCP or reach out to a local patient advocacy group"
X Link 2026-01-19T12:37Z [----] followers, [---] engagements

"What do patients need to know about extrapulmonary neuroendocrine carcinoma (EP-NEC) EP-NEC is a rare and complex cancer that can be difficult to recognise diagnose and treat 📺Watch the video to find out more about navigating EP-NEC: - Why urgency is needed in diagnosis & treatment - The potential of investigational treatments - Where to find support See more of this programme: 🤝Endorsed by: INCA (@netcancerday) @NECancerAus @ncukcharity @NCFCancer @CureNETs & Minkahz NETs Mission Supported by an Independent Educational Grant from Boehringer Ingelheim #MedEd #PatientEducation"
X Link 2026-01-30T12:41Z [----] followers, [---] engagements

"Exploring the role of targeted radiopharmaceutical treatment in #NETs Experts discuss PRRT and emerging strategies in #neuroendocrine tumours w/ Dr @helops79 @ProfKHerrmann Moderated by @OncBrothers 📹 Watch the video 🤝 Endorsed by @NANETS1 CommNETs (@GICancer) & @ncukcharity Supported by an Independent Educational Grant from ITM #MedEd #OncTwitter #MedTwitter #EndoTwitter https://twitter.com/i/web/status/2019777349298839874 https://twitter.com/i/web/status/2019777349298839874"
X Link 2026-02-06T14:17Z [----] followers, [---] engagements

"Are you an oncologist treating patients with neuroendocrine carcinoma Share your insights in this online survey: Neuroendocrine carcinoma is a highly aggressive disease and there remains a substantial need to improve clinical understanding and treatment approaches. Insights from clinicians with direct experience are essential to support ongoing research therapeutic development and patient support. We are pleased to reshare this survey thank you for sharing your perspective https://s-hab.medefield.com/wix/p815281845564.aspx Do you treat patients with Neuroendocrine Carcinoma If so we invite"
X Link 2026-02-09T10:57Z [----] followers, [---] engagements

"Thriving beyond an EP-NEC diagnosis: Perspectives on treatment and care 📺 Video for patients & care partners From Jessica Thomas Director of Patient Education at the Neuroendocrine Tumor Research Foundation Explore: -EP-NEC in context -The complexity and burden of the disease -The concept of thrivership 🤝 Endorsed by @CureNETs & Minkahz NETs Mission See more of this programme: Supported by an Independent Educational Grant from Boehringer Ingelheim #MedEd #OncTwitter #neuroendocrine https://cor2ed.com/net-connect/programmes/thriving-beyond-ep-nec-diagnosis/"
X Link 2026-02-13T08:13Z [----] followers, [---] engagements

"NETs: Understanding key clinical studies like COMPETE and NETTER-1 and [---] helps you pair the right patient with the right treatment ✅ What else do you need to know about radiopharmaceutical treatment for #NETs Experts discuss management strategies future directions and more 📹 Video from Dr @helops79 @ProfKHerrmann @OncBrothers 🤝 Endorsed by @NANETS1 CommNETs (@GICancer) & @ncukcharity Supported by an Independent Educational Grant from ITM #MedEd #OncTwitter #MedTwitter #EndoTwitter https://twitter.com/i/web/status/2009539388330680504 https://twitter.com/i/web/status/2009539388330680504"
X Link 2026-01-09T08:15Z [----] followers, [---] engagements

"What do patients need to know about extrapulmonary neuroendocrine carcinoma (EP-NEC) EP-NEC is a rare and complex cancer that can be difficult to recognise diagnose and treat 📺 Watch the video to find out more about navigating EP-NEC: - Why urgency is needed in diagnosis & treatment - The potential of investigational treatments - Where to find support Endorsed by: INCA (@netcancerday) .@NECancerAus @ncukcharity @NCFCancer @CureNETs & Minkahz NETs Mission Supported by an Independent Educational Grant from Boehringer Ingelheim"
X Link 2026-02-15T12:03Z [----] followers, 112.4K engagements

"Thriving beyond an EP-NEC diagnosis: Perspectives on treatment and care 📺 Video for patients & care partners From Jessica Thomas Director of Patient Education at the Neuroendocrine Tumor Research Foundation Explore: -EP-NEC in context -The complexity and burden of the disease -The concept of thrivership Endorsed by @CureNETs & Minkahz NETs Mission Supported by an Independent Educational Grant from Boehringer Ingelheim https://x.com/net_connectinfo/status/2023007559469150615/video/1 https://x.com/net_connectinfo/status/2023007559469150615/video/1"
X Link 2026-02-15T12:12Z [----] followers, 104.2K engagements

"📣 Video podcast 📣 Understanding EP-NEC: Through diagnosis treatment and support w/ Medical Oncologist Dr @AmanChauhanMD + Neuroendocrine Patient Advocate Susan Meckler-Plummer RN 📹 Highlights in this post Watch the full video or listen on Spotify/Apple: 🤝 Endorsed by Minkahz NETs Mission @ncukcharity @NCFCancer and @CureNETs For more information or support please speak with an HCP or reach out to a local patient advocacy group in your country or region Supported by an Independent Educational Grant from Boehringer Ingelheim #MedEd #NET #EndoTwitter #LetsTalkAboutNETs"
X Link 2026-02-16T12:42Z [----] followers, [---] engagements

"Thriving beyond an EP-NEC diagnosis: Perspectives on treatment and care 📺 Video for patients & care partners From Jessica Thomas Director of Patient Education at the Neuroendocrine Tumor Research Foundation Explore: -EP-NEC in context -The complexity and burden of the disease -The concept of thrivership Endorsed by @CureNETs & Minkahz NETs Mission Supported by an Independent Educational Grant from Boehringer Ingelheim https://x.com/net_connectinfo/status/2023007559469150615/video/1 https://x.com/net_connectinfo/status/2023007559469150615/video/1"
X Link 2026-02-15T12:12Z [----] followers, 104.2K engagements

"What do patients need to know about extrapulmonary neuroendocrine carcinoma (EP-NEC) EP-NEC is a rare and complex cancer that can be difficult to recognise diagnose and treat 📺 Watch the video to find out more about navigating EP-NEC: - Why urgency is needed in diagnosis & treatment - The potential of investigational treatments - Where to find support Endorsed by: INCA (@netcancerday) .@NECancerAus @ncukcharity @NCFCancer @CureNETs & Minkahz NETs Mission Supported by an Independent Educational Grant from Boehringer Ingelheim"
X Link 2026-02-15T12:03Z [----] followers, 112.4K engagements

"Do you treat patients with Neuroendocrine Carcinoma If so we invite you to participate in the survey linked below. Neuroendocrine carcinoma is an aggressive disease with significant unmet clinical needs and advancing research and therapeutic development depends on insights from clinicians actively caring for these patients. Survey link: Thank you for your time and for contributing to progress in this challenging disease area. Please help us spread the word @helops79 @OncoThor @marklewismd @NVijayvergiaMD @JaydiDelRivero @OncBrothers @ajumathew_ @GlopesMd @hosein @Dr_Estelamari_R @NANETS1"
X Link 2026-01-27T23:23Z [----] followers, [----] engagements

"Exploring the role of targeted radiopharmaceutical treatment in #NETs Experts discuss PRRT and emerging strategies in #neuroendocrine tumours w/ Dr @helops79 @ProfKHerrmann Moderated by @OncBrothers 📹 Watch the video 🤝 Endorsed by @NANETS1 CommNETs (@GICancer) & @ncukcharity Supported by an Independent Educational Grant from ITM #MedEd #OncTwitter #MedTwitter #EndoTwitter https://twitter.com/i/web/status/2019777349298839874 https://twitter.com/i/web/status/2019777349298839874"
X Link 2026-02-06T14:17Z [----] followers, [---] engagements

"Understanding EP-NEC: Through diagnosis treatment and support What do you need to know Video podcast from Medical Oncologist Dr @AmanChauhanMD + Neuroendocrine Patient Advocate Susan Meckler-Plummer RN Get answers to questions such as: -How are NETs and NECs different from one another -Why is there such urgency when treating EP-NECs -What needs remain for treatment -What support is available for patients and care partners 📹 Watch the highlights in this post Endorsed by Minkahz NETs Mission @ncukcharity @NCFCancer and @CureNETs For more information or support please speak with an HCP or"
X Link 2026-02-03T13:14Z [----] followers, 297.6K engagements

"NETs: Understanding key clinical studies like COMPETE and NETTER-1 and [---] helps you pair the right patient with the right treatment ✅ What else do you need to know about radiopharmaceutical treatment for #NETs Experts discuss management strategies future directions and more 📹 Video from Dr @helops79 @ProfKHerrmann @OncBrothers 🤝 Endorsed by @NANETS1 CommNETs (@GICancer) & @ncukcharity Supported by an Independent Educational Grant from ITM #MedEd #OncTwitter #MedTwitter #EndoTwitter https://twitter.com/i/web/status/2009539388330680504 https://twitter.com/i/web/status/2009539388330680504"
X Link 2026-01-09T08:15Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing